Neuronetics stock holds after August 11 earnings beat
Published on 09/19/2026 at 14:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Neuronetics stock (ISIN US63009R1005) closed at USD 2.90 on September 19, 2026, while the latest quarter delivered EPS of minus USD 0.05 and revenue of USD 41.57 million. The shares trade on Nasdaq under STIM.
August 11 sets the tone
According to MarketBeat, Neuronetics, Inc. issued its earnings results on August 11, 2026, reported EPS of minus USD 0.05 and revenue of USD 41.57 million, and beat the consensus EPS estimate of minus USD 0.12 by USD 0.07. MarketBeat also put the stock's consensus price target at USD 4.67.
That leaves the gap to the target at 61.0 percent against the USD 2.90 close. The same overview shows 5 buy ratings, no hold ratings and 1 sell rating.
Price versus range
MarketBeat's stock page listed a 52-week range of USD 0.80 to USD 3.44, market capitalization of USD 220.98 million and volume of 1.12 million shares. Against that band, the USD 2.90 close sits 15.7 percent below the 52-week high and 262.5 percent above the low.
For investors, the numbers say the same thing from two angles: the August 11 report showed an EPS beat, but the stock still traded below the target and below the top of its 52-week range.
What matters next
At the same time, the price action suggests the next catalyst will matter more than the prior beat. A move back toward USD 3.44 would put the 52-week high back in view.
Neuronetics stock at a glance
- Company: Neuronetics, Inc.
- ISIN: US63009R1005
- Ticker: STIM
- Trading venue: Nasdaq
- Price (as of September 19, 2026): USD 2.90
- Market capitalization: USD 220.98 million (as of September 19, 2026)
- Sector / Industry: Healthcare / Healthcare Equipment and Supplies
- Index membership: None identified in the available market snapshot
